Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PURE BIOSCIENCE, INC.

Get SEC filing alerts via email and in your feed for PURE BIOSCIENCE, INC.

PURE

PURE BIOSCIENCE, INC.

About PURE BIOSCIENCE, INC.

PURE Bioscience, Inc. develops proprietary antimicrobial products based on patented stabilized ionic silver, primarily containing Silver Dihydrogen Citrate (SDC). Its core offerings include food contact surface disinfectants, sanitizers, and processing aids aimed at food safety, healthcare, and facility sanitation markets. The company emphasizes non-toxic, environmentally friendly solutions with broad pathogen efficacy, leveraging licensing, distribution, and strategic partnerships to address global hygiene challenges.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PURE BIOSCIENCE, INC.

1
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports $1.25M Net Loss Despite 22% Revenue Growth

Via official filing (AI summary) | 3 months ago | 0 comments

2
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports 27% Revenue Growth but Net Loss of $464,000 for Quarter Ending October 31, 2025

Via official filing (AI summary) | 6 months ago | 0 comments

3
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports $2.20 Million Revenue with Net Loss of $2.40 Million for Fiscal Year Ending July 31, 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports $2.067 Million Net Loss and Decreased Revenue for Nine Months Ending April 30, 2025

Via official filing (AI summary) | 12 months ago | 0 comments

5
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports $1.487 Million Net Loss and Decreased Revenue in Q2 FY 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PURE BIOSCIENCE, INC. PURE Bioscience Reports $689,000 Net Loss and Decreased Revenue for Quarter Ending October 31, 2024

Via official filing (AI summary) | over 1 year ago | 0 comments